NCT01641510View on ClinicalTrials.gov

PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2018

Study Completion Date

February 28, 2019

Conditions
Acute Coronary Syndromes
Interventions
DRUG

Prasugrel

Loading with prasugrel 30 mg followed by daily administration of prasugrel 5 mg

DRUG

Clopidogrel

Loading with clopidogrel 600 mg followed by daily administration of clopidogrel 75 mg

Trial Locations (1)

Unknown

DongA University Hospital, Busan

All Listed Sponsors
lead

Dong-A University

OTHER

NCT01641510 - PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants | Biotech Hunter | Biotech Hunter